Home › Funds › T. Rowe Price › T. Rowe Price Extended Equity Market Index Fund
Fund family: T. Rowe Price · Filed by T. Rowe Price Index Trust, Inc. (CIK 858581) · SEC series S000002090
Ticker: PEXMX (C000005458)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 13,606 with, 102 against, 0 abstentions (not counted as with management); 3 items carried no recommendation. Shareholder proposals: 31 FOR, 66 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | T. Rowe Price | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 88.5% | 13,255 | 93.7% | 208,710 |
| Backed environmental and social shareholder proposals at US companies | n/a | 23 | 2.6% | 3,333 |
Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most T. Rowe Price funds on 120 items (1.9% of the 6,231 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most T. Rowe Price funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Avalo Therapeutics, Inc. | 2026-06-02 | To approve the Avalo Therapeutics, Inc. Second Amended and Restated 2016 Employee Stock Purchase Plan; | Against | FOR — 8 of 8 T. Rowe Price funds | Against | — |
| Immunovant, Inc. | 2025-08-27 | To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Douglas Hughes | Withhold | FOR — 8 of 9 T. Rowe Price funds | Against | Elected, 89.5% support |
| Goosehead Insurance, Inc. | 2026-05-04 | Election of Directors: Robyn Jones | For | WITHHOLD — 7 of 8 T. Rowe Price funds | For | Elected, 77.3% support |
| Goosehead Insurance, Inc. | 2026-05-04 | Election of Directors: William Wade, Jr. | For | WITHHOLD — 7 of 8 T. Rowe Price funds | For | Elected, 77.3% support |
| Middlesex Water Company | 2026-05-19 | Election of Directors: Vaughn L. McKoy | For | WITHHOLD — 7 of 8 T. Rowe Price funds | For | Passed (calculated), 79.7% support |
| Vishay Precision Group, Inc. | 2026-05-19 | Election of Directors: Nava Swersky Sofer | For | WITHHOLD — 7 of 8 T. Rowe Price funds | For | — |
| Vishay Precision Group, Inc. | 2026-05-19 | Election of Directors: Saul Reibstein | For | WITHHOLD — 7 of 8 T. Rowe Price funds | For | — |
| Vishay Precision Group, Inc. | 2026-05-19 | Election of Directors: Sejal Shah Gulati | For | WITHHOLD — 7 of 8 T. Rowe Price funds | For | — |
| Texas Capital Bancshares, Inc. | 2026-04-21 | To elect ten (10) directors - each to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Thomas E. Long | For | WITHHOLD — 7 of 8 T. Rowe Price funds | For | Elected, 85.7% support |
| TWFG, Inc. | 2026-05-27 | Elect each of the six director nominees for a one-year term: Janet S. Wong | Withhold | FOR — 7 of 8 T. Rowe Price funds | Against | — |
| TWFG, Inc. | 2026-05-27 | Elect each of the six director nominees for a one-year term: Jonathan Anderson | Withhold | FOR — 7 of 8 T. Rowe Price funds | Against | — |
| TWFG, Inc. | 2026-05-27 | Elect each of the six director nominees for a one-year term: Michael Doak | Withhold | FOR — 7 of 8 T. Rowe Price funds | Against | — |
| TWFG, Inc. | 2026-05-27 | Elect each of the six director nominees for a one-year term: Robin A. Ferracone | Withhold | FOR — 7 of 8 T. Rowe Price funds | Against | — |
| Loar Holdings Inc. | 2026-06-02 | 3 wordings Election of Raja Bobbili, Alison Bomberg and Margaret (Peg) McGetrick as Class II directors, each to hold office until our annual meeting of stockholders in 2029 and until their successor is duly elected and qualified, or until their earlier death, resignation, or removal: Raja Bobbili | Withhold | FOR — 9 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.6% support |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: Elisabeth Torstad | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | — |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: George A. Williams | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | Elected, 99.7% support |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: James M. Shannon | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | Elected, 99.8% support |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: James P. Dollive | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | Elected, 99.6% support |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: Marla C. Gottschalk | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | Elected, 99.8% support |
| UL Solutions Inc. | 2026-05-20 | Election of Directors: Sally Susman | Withhold | FOR — 10 of 13 T. Rowe Price funds | Against | Elected, 99.9% support |
| GPGI, Inc. | 2026-06-11 | Election of Directors: Brian F. Hughes | Withhold | FOR — 6 of 7 T. Rowe Price funds | Against | Passed (calculated), 97.8% support |
| GPGI, Inc. | 2026-06-11 | Election of Directors: Joseph J. DeAngelo | Withhold | FOR — 6 of 7 T. Rowe Price funds | Against | Passed (calculated), 99.8% support |
| GPGI, Inc. | 2026-06-11 | Election of Directors: Mark R. James | Withhold | FOR — 6 of 7 T. Rowe Price funds | Against | Passed (calculated), 92.2% support |
| OceanFirst Financial Corp. | 2026-04-02 | A proposal to approve the issuance of (a) OceanFirst common stock to holders of Flushing common stock (the "Flushing stockholders") pursuant to the merger agreement and (b) OceanFirst common stock, a new class of non-voting, common-equivalent stock of OceanFirst ("OceanFirst NVCE stock") and a warra | For | AGAINST — 6 of 7 T. Rowe Price funds | For | Approved, 94.3% support |
| Kearny Financial Corp. | 2025-10-21 | The election of the five nominees listed, for the term indicated: Christopher Petermann, three-year term | For | WITHHOLD — 6 of 7 T. Rowe Price funds | For | Passed (calculated), 88.4% support |
| Company | Meeting | Item | This fund | Most T. Rowe Price funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Kearny Financial Corp. | 2025-10-21 | The election of the five nominees listed, for the term indicated: John F. McGovern, three-year term | For | WITHHOLD — 6 of 7 T. Rowe Price funds | For | Passed (calculated), 86.2% support |
| Kearny Financial Corp. | 2025-10-21 | The election of the five nominees listed, for the term indicated: John J. Mazur, Jr., three-year term | For | WITHHOLD — 6 of 7 T. Rowe Price funds | For | Passed (calculated), 82.9% support |
| Cytokinetics, Incorporated | 2026-05-27 | 2 wordings Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D. | Withhold | FOR — 15 of 22 T. Rowe Price funds | Against | Passed (calculated), 97.0% support |
| Noble Corporation plc | 2026-04-29 | Authorization of the Board to Allot Shares without Rights of Pre-Emption. | Against | FOR — 7 of 9 T. Rowe Price funds | Against | Approved, 81.0% support |
| Noble Corporation plc | 2026-04-29 | Authorization of the Board to Allot Shares. | Against | FOR — 7 of 9 T. Rowe Price funds | Against | — |
| Adaptive Biotechnologies Corporation | 2026-06-05 | To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders: Robert Hershberg, PhD, MD | For | WITHHOLD — 7 of 9 T. Rowe Price funds | For | — |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Jody A. Markopoulos | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: John W. Kuo | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Kenneth C. Bockhorst | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Lawrence D. Kingsley | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Robert A. Cascella | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Sheila Rege | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mirion Technologies, Inc. | 2026-05-13 | Elect directors for a one-year term: Steven W. Etzel | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Passed (calculated), 100.0% support |
| Mercury Systems, Inc. | 2025-10-22 | To elect three Class I directors nominated by the Board of Directors, each to serve for a three-year term, and in each case until their successors have been duly elected and qualified: Howard L. Lance | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | — |
| Mercury Systems, Inc. | 2025-10-22 | To elect three Class I directors nominated by the Board of Directors, each to serve for a three-year term, and in each case until their successors have been duly elected and qualified: Lisa S. Disbrow | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | — |
| Applied Optoelectronics, Inc. | 2026-06-04 | Class I Directors for Election: Che-Wei Lin | For | WITHHOLD — 7 of 9 T. Rowe Price funds | For | — |
| Applied Optoelectronics, Inc. | 2026-06-04 | Class I Directors for Election: Robert (Bob) Flanagan | For | WITHHOLD — 7 of 9 T. Rowe Price funds | For | — |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Blake W. Augsburger | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 97.4% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Denis G. Suggs | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 93.5% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: John A. Forbes | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 92.6% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Joseph M. Cerulli | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 83.6% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: M. Scott Welch | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 93.4% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Michael A. Kitson | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 96.3% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Natalie A. Brown | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 94.3% support |
| Patrick Industries, Inc. | 2026-05-14 | To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Todd M. Cleveland | Withhold | FOR — 7 of 9 T. Rowe Price funds | Against | Elected, 96.5% support |
| Peloton Interactive, Inc. | 2025-12-09 | Election of Directors: Chris Bruzzo | For | WITHHOLD — 7 of 9 T. Rowe Price funds | For | Elected, 77.8% support |
| Root, Inc. | 2026-06-03 | To elect three Class III directors, Lawrence Hilsheimer, Alexander Timm and Douglas Ulman, each to hold office until our Annual Meeting of Stockholders in 2029: Lawrence Hilsheimer | For | AGAINST — 7 of 9 T. Rowe Price funds | For | Elected, 92.8% support |
| Ryan Specialty Holdings, Inc. | 2026-04-28 | Election five director nominees: Anthony J. Kuczinski | Against | FOR — 5 of 6 T. Rowe Price funds | Against | — |
| Ryan Specialty Holdings, Inc. | 2026-04-28 | Election five director nominees: Michael G. Bungert | Against | FOR — 5 of 6 T. Rowe Price funds | Against | Elected, 99.8% support |
| Service Corporation International | 2026-05-06 | Election of Directors: Marcus A. Watts | For | AGAINST — 12 of 18 T. Rowe Price funds | For | Failed (calculated), 43.5% support |
| Service Corporation International | 2026-05-06 | To approve the 2026 Equity Incentive Plan. | Against | FOR — 12 of 18 T. Rowe Price funds | Against | Approved, 78.1% support |
| CRISPR Therapeutics AG | 2026-06-04 | Binding vote on maximum equity for members of the Executive Committee from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. | Against | FOR — 5 of 6 T. Rowe Price funds | Against | — |
| CRISPR Therapeutics AG | 2026-06-04 | Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027. | Against | FOR — 5 of 6 T. Rowe Price funds | Against | — |
| CRISPR Therapeutics AG | 2026-06-04 | Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026. | Against | FOR — 5 of 6 T. Rowe Price funds | Against | — |
| CRISPR Therapeutics AG | 2026-06-04 | Non-binding advisory vote on the 2025 Compensation Report. | Against | FOR — 5 of 6 T. Rowe Price funds | Against | — |
| CRISPR Therapeutics AG | 2026-06-04 | Re-election of Ali Behbahani, M.D. | For | AGAINST — 5 of 6 T. Rowe Price funds | For | — |
| CRISPR Therapeutics AG | 2026-06-04 | Re-election of the members of the Compensation Committee: Re-election of Ali Behbahani, M.D. | For | AGAINST — 5 of 6 T. Rowe Price funds | For | — |
| BJ's Wholesale Club Holdings, Inc. | 2026-06-18 | Shareholder Vote on a shareholder proposal regarding a report on deforestation in the company's own-brand supply chain, if properly presented at the meeting. | For | AGAINST — 8 of 11 T. Rowe Price funds | Against | — |
| BJ's Wholesale Club Holdings, Inc. | 2026-06-18 | Shareholder Vote on a shareholder proposal regarding a report on greenhouse gas emissions reduction efforts, if properly presented at the meeting. | For | AGAINST — 8 of 11 T. Rowe Price funds | Against | — |
| IonQ, Inc. | 2026-06-16 | To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: Kathryn K. Chou | Withhold | FOR — 6 of 8 T. Rowe Price funds | Against | Elected, 71.3% support |
| IonQ, Inc. | 2026-06-16 | To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: William F. Scannell | Withhold | FOR — 6 of 8 T. Rowe Price funds | Against | Elected, 83.0% support |
| Prosperity Bancshares, Inc. | 2026-04-21 | Election of four (4) Class I directors to serve on the Board of Directors of the Company until the Company's 2029 annual meeting of shareholders: Harrison Stafford II (Class I) | Withhold | FOR — 6 of 8 T. Rowe Price funds | Against | Passed (calculated), 96.3% support |
| Prosperity Bancshares, Inc. | 2026-04-21 | Election of four (4) Class I directors to serve on the Board of Directors of the Company until the Company's 2029 annual meeting of shareholders: Perry Mueller, Jr. (Class I) | Withhold | FOR — 6 of 8 T. Rowe Price funds | Against | Passed (calculated), 87.8% support |
| CRISPR Therapeutics AG | 2026-06-04 | Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements. | Against | FOR — 6 of 8 T. Rowe Price funds | Against | Approved, 69.4% support |
| Kadant Inc. | 2026-05-20 | Election of two directors to the class to be elected for a three-year term expiring in 2029: Thomas C. Leonard | Against | FOR — 6 of 8 T. Rowe Price funds | Against | — |
| Surgery Partners, Inc. | 2026-06-05 | Election of Class II Directors: Brent Turner | Withhold | FOR — 6 of 8 T. Rowe Price funds | Against | Elected, 96.9% support |
| PBF Energy Inc. | 2026-04-28 | Election of Directors: Spencer Abraham | Against | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 89.4% support |
| Element Solutions Inc | 2026-05-04 | Election of Directors: E. Stanley O'Neal | For | AGAINST — 7 of 10 T. Rowe Price funds | For | Passed (calculated), 94.2% support |
| ESCO Technologies Inc. | 2026-01-30 | Election of Directors: Patrick M. Dewar | Withhold | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 96.4% support |
| ESCO Technologies Inc. | 2026-01-30 | Election of Directors: Vinod M. Khilnani | Withhold | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 96.6% support |
| Flagstar Bank, N.A. | 2026-06-09 | Election of Directors: Marshall Lux | Against | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 98.0% support |
| Ambarella, Inc. | 2026-06-26 | Election of Directors: D. Jeffrey Richardson | Withhold | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 89.0% support |
| Ambarella, Inc. | 2026-06-26 | Election of Directors: Elizabeth M. Schwarting | Withhold | FOR — 7 of 10 T. Rowe Price funds | Against | Elected, 80.4% support |
| Oscar Health, Inc. | 2026-06-04 | Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: David Alexander Plouffe | Withhold | FOR — 8 of 12 T. Rowe Price funds | Against | Passed (calculated), 99.5% support |
| Oscar Health, Inc. | 2026-06-04 | Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Siddhartha Sankaran | Withhold | FOR — 8 of 12 T. Rowe Price funds | Against | Passed (calculated), 99.7% support |
| Oscar Health, Inc. | 2026-06-04 | Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: William (Bill) J. Gassen III | Withhold | FOR — 8 of 12 T. Rowe Price funds | Against | Passed (calculated), 96.9% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Abid Rizvi | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.8% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Alissa Ahlman | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.8% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Mary Baglivo | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.8% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Richard Zannino | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 95.8% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Robert Fisch | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.3% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stanley Fleishman | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 90.7% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stephen White | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.5% support |
| Ollie's Bargain Outlet Holdings, Inc. | 2026-06-11 | Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Thomas Hendrickson | Against | FOR — 9 of 14 T. Rowe Price funds | Against | Passed (calculated), 97.0% support |
| Element Solutions Inc | 2026-05-04 | Advisory vote to approve the Company's 2025 executive compensation | Against | FOR — 8 of 13 T. Rowe Price funds | Against | Failed (calculated), 41.4% support |
| Dutch Bros Inc. | 2026-05-13 | Election of Directors: Todd Penegor | For | AGAINST — 10 of 17 T. Rowe Price funds | For | Elected, 91.7% support |
| Dutch Bros Inc. | 2026-05-13 | Election of Directors: Travis Boersma | For | AGAINST — 10 of 17 T. Rowe Price funds | For | Elected, 95.6% support |
| Flagstar Bank, N.A. | 2026-06-09 | An advisory vote to approve, on a non-binding basis, compensation of our named executive officers disclosed in the accompanying proxy statement. | Against | FOR — 8 of 13 T. Rowe Price funds | Against | Passed (calculated), 81.2% support |
| Pinnacle Financial Partners, Inc. | 2025-11-06 | A proposal to approve and adopt the Agreement and Plan of Merger by and among Pinnacle Financial Partners, Inc. ("Pinnacle"), Synovus Financial Corp. ("Synovus") and Steel Newco Inc. ("Newco"), dated as of July 24, 2025 (as amended from time to time, the "merger agreement"), pursuant to which, on th | For | AGAINST — 6 of 9 T. Rowe Price funds | For | — |
| Clean Harbors, Inc. | 2026-05-20 | To elect four (4) Class I members of the Board of Directors of the Company to serve until the 2029 Annual Meeting of Shareholders: John R. Welch | Withhold | FOR — 6 of 9 T. Rowe Price funds | Against | Passed (calculated), 98.5% support |
| Clean Harbors, Inc. | 2026-05-20 | To elect four (4) Class I members of the Board of Directors of the Company to serve until the 2029 Annual Meeting of Shareholders: Shelley Stewart, Jr. | Withhold | FOR — 6 of 9 T. Rowe Price funds | Against | Passed (calculated), 99.4% support |
| Advanced Energy Industries, Inc. | 2026-05-07 | Approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan; and | Against | FOR — 6 of 9 T. Rowe Price funds | Against | Approved, 78.4% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Amin N. Maredia | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Edward N. Antoian | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 97.6% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Harry S. Cherken, Jr. | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.4% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: John C. Mulliken | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 97.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Kelly Campbell | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 99.3% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Mary C. Egan | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.7% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Todd R. Morgenfeld | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 99.1% support |
| Urban Outfitters, Inc. | 2026-06-03 | Election of Directors: Wesley S. McDonald | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Passed (calculated), 98.3% support |
| Interparfums, Inc. | 2025-09-10 | To vote for the advisory resolution to approve executive compensation. | Against | FOR — 7 of 11 T. Rowe Price funds | Against | Approved, 84.3% support |
| Marqeta, Inc. | 2026-06-10 | To approve an amendment to our Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law. | For | AGAINST — 7 of 11 T. Rowe Price funds | For | Passed (calculated), 78.7% support |
| Marqeta, Inc. | 2026-06-10 | To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Judson (Jud) Li | For | WITHHOLD — 7 of 11 T. Rowe Price funds | For | Passed (calculated), 92.2% support |
| Marqeta, Inc. | 2026-06-10 | To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Martha Cummings | For | WITHHOLD — 7 of 11 T. Rowe Price funds | For | Passed (calculated), 82.1% support |
| Marqeta, Inc. | 2026-06-10 | To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Najuma Atkinson | For | WITHHOLD — 7 of 11 T. Rowe Price funds | For | Passed (calculated), 87.8% support |
| Marqeta, Inc. | 2026-06-10 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | For | AGAINST — 8 of 14 T. Rowe Price funds | For | Passed (calculated), 78.5% support |
| Installed Building Products, Inc. | 2026-05-19 | Election of Directors to serve for three-year terms: Robert H. Schottenstein | Against | FOR — 7 of 12 T. Rowe Price funds | Against | Elected, 93.9% support |
| Denali Therapeutics Inc. | 2026-06-03 | ELECTION OF DIRECTORS: David Schenkein, M.D. | For | WITHHOLD — 8 of 15 T. Rowe Price funds | For | Elected, 73.5% support |
| Denali Therapeutics Inc. | 2026-06-03 | ELECTION OF DIRECTORS: Jennifer Cook | For | WITHHOLD — 8 of 15 T. Rowe Price funds | For | Elected, 60.9% support |
| Impinj, Inc. | 2026-05-28 | Election of Directors: Steve Sanghi | For | AGAINST — 7 of 13 T. Rowe Price funds | For | Elected, 68.1% support |
| Atlassian Corporation | 2025-12-02 | Election of Directors: Christian Smith | For | AGAINST — 3 of 5 T. Rowe Price funds | For | Passed (calculated), 99.8% support |
| Atlassian Corporation | 2025-12-02 | Election of Directors: Richard P. Wong | For | AGAINST — 3 of 5 T. Rowe Price funds | For | Passed (calculated), 94.8% support |
| Atlassian Corporation | 2025-12-02 | Election of Directors: Shona L. Brown | For | AGAINST — 3 of 5 T. Rowe Price funds | For | Passed (calculated), 96.3% support |
| Arrow Electronics, Inc. | 2026-05-12 | Shareholder Shareholder proposal to provide shareholders with the ability to call a special shareholder meeting at a 10% ownership threshold. | Against | FOR — 3 of 5 T. Rowe Price funds | For | — |
| Symbotic Inc. | 2026-03-05 | To approve an advisory vote on the compensation paid to our named executive officers. | For | AGAINST — 2 of 3 T. Rowe Price funds | For | Passed (calculated), 99.0% support |
Download all 120 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 96.1% of this fund’s 13,708 such votes could be given a sector; the other 529 (3.9%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 3,031 | 47 | 1.6% |
| Finance | 2,501 | 8 | 0.3% |
| Industrials | 1,811 | 14 | 0.8% |
| Technology | 1,663 | 9 | 0.5% |
| Health Care | 1,639 | 12 | 0.7% |
| Real Estate | 865 | 2 | 0.2% |
| Energy | 532 | 0 | 0.0% |
| Utilities | 380 | 2 | 0.5% |
| Consumer Staples | 265 | 6 | 2.3% |
| Miscellaneous | 202 | 0 | 0.0% |
| Telecommunications | 154 | 1 | 0.6% |
| Basic Materials | 136 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 9,526 | 16 |
| Say-on-Pay | 1,595 | 0 |
| Audit-related | 1,490 | 0 |
| Compensation | 506 | 0 |
| Corporate Governance | 363 | 54 |
| Extraordinary Transactions | 143 | 1 |
| Capital Structure | 142 | 1 |
| Shareholder Rights and Defenses | 52 | 7 |
| Environment or Climate | 12 | 12 |
| Other Social Issues | 7 | 7 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Sandisk Corporation | November 18, 2025 | $17M | 10 | 0 |
| Marvell Technology, Inc. | June 25, 2026 | $17M | 10 | 1 |
| Snowflake Inc. | June 29, 2026 | $13M | 6 | 1 |
| Snowflake Inc. | July 2, 2025 | $13M | 7 | 0 |
| Cloudflare, Inc. | June 30, 2026 | $13M | 14 | 0 |
| Cheniere Energy, Inc. | May 14, 2026 | $9M | 11 | 0 |
| Ferguson Enterprises Inc. | December 3, 2025 | $7M | 13 | 0 |
| Ferguson Enterprises Inc. | April 30, 2026 | $7M | 13 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 25, 2026 | Marvell Technology, Inc. | To consider and act on one stockholder proposal, entitled "Independent Board Chairman", if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| June 29, 2026 | Snowflake Inc. | To consider and vote on, if properly presented at the meeting, a non-binding stockholder proposal requesting majority vote for director elections. Shareholder proposal | For | Against |
| September 3, 2025 | Casey's General Stores, Inc. | Shareholder proposal regarding Scope 3 greenhouse gas reduction targets. Shareholder proposal | Against | For |
| May 6, 2026 | Entegris, Inc. | Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposal | Against | For |
| May 20, 2026 | Markel Group Inc. | Shareholder proposal for a report on the Company's strategies and action plans to mitigate material environmental risks. Shareholder proposal | Against | For |
| May 20, 2026 | Markel Group Inc. | Shareholder proposal to give shareholders an ability to call for a special shareholder meeting. Shareholder proposal | Against | For |
| May 20, 2026 | Reliance, Inc. | To consider a stockholder proposal requiring any director who fails to receive a majority vote to leave the board of directors within nine months. Shareholder proposal | Against | For |
| May 4, 2026 | First Citizens BancShares, Inc. | Proposal requesting a report on faith-based employee resource groups. Shareholder proposal | Against | For |
| January 12, 2026 | Zscaler, Inc. | To vote on a non-binding stockholder proposal requesting the declassification of our board of directors. Shareholder proposal | For | Against |
| June 1, 2026 | DocuSign, Inc. | A stockholder proposal to report on the risks of non-fiduciary executive compensation metrics, if properly presented at the meeting Shareholder proposal | Against | For |
| May 15, 2026 | Medpace Holdings, Inc. | Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposal | Against | For |
| May 11, 2026 | MKS Inc. | A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposal | Against | For |
Meetings with a proxy contest or competing nominees (10 in 2025-2026), and how the fund voted the items on its ballot.
13,840 ballot items at 1,621 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, T. Rowe Price Extended Equity Market Index Fund (PEXMX) voted at 1,621 shareholder meetings of 1,548 companies, on 13,840 ballot items in all. Where management made a recommendation, the fund followed it on 99.3% of the items and voted against it 102 times. Its most frequent area of disagreement was corporate governance (54 of its votes against management). It voted FOR 32.0% of the 97 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (88.5% against 93.7%). It voted differently from most T. Rowe Price funds on 120 items. 10 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.